microRNA-21 is upregulated in malignant melanoma and influences apoptosis of melanocytic cells

Experimental Dermatology

Volumn 21, Issue 7, 2012, Pages 509-514

  Satzger, Imke ^a   Mattern, Anika ^a   Kuettler, Uta ^a   Weinspach, Dirk ^a,b   Niebuhr, Margarete ^a   Kapp, Alexander ^a   Gutzmer, Ralf ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Apoptosis; Cell cycle; Melanoma; MicroRNA; Proliferation

Indexed keywords

MICRORNA 21; PROTEIN TYROSINE PHOSPHATASE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER PROGNOSIS; CANCER TISSUE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MELANOCYTE; MELANOCYTIC NEVUS; MELANOMA; PATHOGENESIS; PRIMARY TUMOR; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETROSPECTIVE STUDY; UPREGULATION;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE-FREE SURVIVAL; DOWN-REGULATION; HUMANS; KAPLAN-MEIER ESTIMATE; MELANOCYTES; MELANOMA; MICRORNAS; NEVUS, PIGMENTED; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; UP-REGULATION;

EID: 84863108845     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2012.01510.x     Document Type: Article

References (27)

1. Curtin J A, Fridlyand J, Kageshita T et al. N Engl J Med 2005: 353: 2135-2147.
2. Herlyn M. Exp Dermatol 2009: 18: 506-508.
3. Holst L M, Kaczkowski B, Gniadecki R. Exp Dermatol 2010: 19: e201-e205.
4. Krichevsky A M, Gabriely G. J Cell Mol Med 2009: 13: 39-53.
5. Satzger I, Mattern A, Küttler U et al. Int J Cancer 2010: 126: 2553-2562.
6. Zeitvogel J, Werfel T, Wittmann M. Exp Dermatol 2008: 17: 998-1003.
7. Wang P, Zou F, Zhang X et al. Cancer Res 2009: 69: 8157-8165.
8. Lawrie C H, Soneji S, Marafioti T et al. Int J Cancer 2007: 121: 1156-1161.
9. Conti A, Aguennouz M, La Torre D et al. J Neurooncol 2009: 93: 325-332.
10. Kwak H J, Kim Y J, Chun K R et al. Oncogene 2011: 30: 2433-2442.
11. Qian B, Katsaros D, Lu L et al. Breast Cancer Res Treat 2009: 117: 131-140.
12. Saito M, Schetter A J, Mollerup S et al. Clin Cancer Res 2011: 17: 1875-1882.
13. Ribas J, Ni X, Haffner M et al. Cancer Res 2009: 69: 7165-7169.
14. Hwang J H, Voortman J, Giovannetti E et al. PLoS One 2010: 5: e10630.
15. Mueller D W, Rehli M, Bosserhoff A K. J Invest Dermatol 2009: 129: 1740-1751.
16. Chen J, Feilotter H E, Pare G C et al. Am J Pathol 2010: 176: 2520-2529.
17. Zhang Y, Li M, Wang H et al. World J Surg 2009: 33: 698-709.
18. Roversi G, Pfundt R, Moroni R F et al. Oncogene 2006: 25: 1571-1583.
19. Hulf T, Sibbritt T, Wiklund E D et al. BMC Genomics 2011: 12: 54.
20. Iorio M V, Visone R, Di Leva G et al. Cancer Res 2007: 67: 8699-8707.
21. Bhatti I, Lee A, James V et al. J Gastrointest Surg 2011: 15: 199-208.
22. Yan L X, Wu Q N, Zhang Y et al. Breast Cancer Res 2011: 13: R2.
23. Curtin J A, Busam K, Pinkel D et al. J Clin Oncol 2006: 24: 4340-4346.
24. Lou Y, Yang X, Wang F et al. Int J Mol Med 2010: 26: 819-827.
25. Zhu S, Si M L, Wu H et al. J Biol Chem 2007: 282: 14328-14336.
26. Pothof J, Verkaik N S, van Ijcken W et al. EMBO J 2009: 28: 2090-2099.
27. Boutros R, Lobjois V, Ducommun B. Nat Rev Cancer 2007: 7: 495-507.